Caxton Associates (UK)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,110
Closed -$370K 752
2025
Q1
$370K Buy
+5,110
New +$370K 0.01% 558